Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Clasificación en acciones #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Precio por acción
$0.12164306
Última sincronización: 2024-11-11
Capitalización bursátil
$38.53M
Cambio (1 día)
-4.14%
Cambio (1 año)
0.00%
País
AU
Comercio PharmAust Limited (PAA)

Categoría

Historial del precio de la acción de PharmAust Limited (PAA)
Precio más alto de cierre: $0.12 el 2024-11-01

Precio más bajo de cierre: $3.11 el 2001-10-01
Historial del precio de la acción de PharmAust Limited desde 2001 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 72.79%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$544.87 38.17%
US
$1.03K 56.37%
NL
$120.74 -14.98%
AU
$139.03 417.03%
US
$762.65 7.15%
CH